NextCure (NASDAQ:NXTC) Earns Buy Rating from HC Wainwright
NextCure (NASDAQ:NXTC – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They presently have a $3.00 target price on the stock. HC Wainwright’s price objective would suggest a potential upside of 418.85% from the company’s current price. NextCure […]
NextCure (NASDAQ:NXTC – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They presently have a $3.00 target price on the stock. HC Wainwright’s price objective would suggest a potential upside of 418.85% from the company’s current price. NextCure […]
